Clinical Trials in Georgia

Showing 5361-5380 of 14,426 trials

Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.

NCT02678741

Assess the safety and tumor response of utilizing an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine given in combination with standard of care (SoC) checkpoint inhibitors (CPI) in patients with stage IV melanoma with measurable disease.

Metastatic Melanoma

Elios Therapeutics, LLC26 participantsStarted Feb 2016

Birmingham, Alabama, United States • Santa Monica, California, United States • Miami Beach, Florida, United States +4 more locations

COMPLETEDPhase 365 miles

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

NCT01412333

This randomized, double-blind, double-dummy, parallel-group study will evaluate the efficacy and safety of ocrelizumab in comparison with interferon beta-1a (Rebif) in participants with relapsing multiple sclerosis. Participants will be randomized to receive either ocrelizumab 600 mg or matching placebo intravenous (IV) as 300 mg infusions on Days 1 and 15 for the first dose and as a single infusion of 600 mg for all subsequent infusions every 24 weeks, with placebo injections matching interferon beta-1a SC three times per week; or interferon beta-1a 44 mcg SC injections three times per week (with placebo infusions matching ocrelizumab infusions every 24 weeks).

Relapsing Multiple Sclerosis

Hoffmann-La Roche835 participantsStarted Sep 2011

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +162 more locations

Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

Find Trials by Condition in Georgia

A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis

Safety and Tolerability of SYNB8802 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria

Effect of Advanced Care at Home vs. Traditional Brick-and-Mortar Hospital Care in Acutely Ill Adults: A Randomized Clinical Trial

Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921

Evaluation of the PrevisEA Device for Predicting Gastrointestinal Impairment

A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19

Association of Platelet Parameters With Bleeding Severity in Children With ITP

HY-0102 Monotherapy in Patients With Locally Advanced/Metastatic Solid Tumours

A Study of Purified Inactivated Zika Virus Vaccine (PIZV) in Healthy Adults

Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)

Prospective SPINE Registry

Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy

Robotic-assisted and Laparoscopic Right Colectomy Study - Intracorporeal vs. Extracorporeal Anastomoses

A Study in Healthy People to Test How 2 Different Formulations of BI 695501 Are Taken up by the Body When Given as an Injection

Assessing Brain Injury Using Portable Magnetic Resonance Imaging (MRI)

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

A Study of hSTC810 With Advanced/Metastatic Solid Tumors (STCUBE-001)

A Patch Free Treatment for Young Children With Amblyopia